Single-cell genomics identifies immune response to neoadjuvant chemoradiotherapy

EBioMedicine. 2022 Dec:86:104389. doi: 10.1016/j.ebiom.2022.104389. Epub 2022 Dec 1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Chemoradiotherapy
  • Esophageal Neoplasms*
  • Genomics
  • Humans
  • Immunity
  • Neoadjuvant Therapy
  • Rectal Neoplasms*
  • Retrospective Studies
  • Treatment Outcome